Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14
View study Tesamorelin was FDA-approved in 2010 (brand name Egrifta) for the reduction of excess abdominal fat in patients with HIV-associated lipodystrophy
Marks are less fine (0.1 mL), so it's a bit less precise for small doses
Patients pursuing structured wellness plans or rapid weight loss programs often benefit from therapies that address hormonal balance alongside lifestyle adjustments
It is intended for controlled laboratory work in which the investigator has already defined the identity criteria, analytical method, handling controls, and lawful research purpose
The peptide functions through beta-3 adrenergic receptor activation in adipose tissue
US$ 27.02
US$ 29.67
US$ 24.33
US$ 22.19
US$ 21.72
